Cue Health (Nasdaq: HLTH) is a healthcare technology company that puts consumers in control of their health information and places diagnostic information at the center of care.
Cue Health enables people to manage their health through real-time, actionable, and connected health information, offering individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand. Cue Health’s first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription and physician supervision.
Outside the United States, Cue Health has received the CE mark in the European Union, Interim Order authorization from Health Canada, and regulatory approval from India’s Central Drugs Standard Control Organisation.
Cue was founded in 2010 and is headquartered in San Diego. For more information, please visit www.cuehealth.com.
Cue Health to Participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference
Aug 03, 2022
SAN DIEGO--(BUSINESS WIRE)--Aug. 3, 2022-- Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Confer...
SAN DIEGO--(BUSINESS WIRE)--Jul. 27, 2022-- Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its second quarter 2022 financial results on Wednesday, August 10, 2022. In conjunctio...
Seasoned Leader Brings Extensive Experience in Building Diverse, Inclusive Healthcare Organizations SAN DIEGO, July 13, 2022 /PRNewswire/ -- Cue Health Inc. ("Cue") (Nasdaq: HLTH), a health technology company, today announced that it has appoi...